taurochenodeoxycholic-acid and Parkinsonian-Disorders

taurochenodeoxycholic-acid has been researched along with Parkinsonian-Disorders* in 2 studies

Other Studies

2 other study(ies) available for taurochenodeoxycholic-acid and Parkinsonian-Disorders

ArticleYear
Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson's disease.
    Biochimica et biophysica acta. Molecular basis of disease, 2017, Volume: 1863, Issue:9

    Impaired mitochondrial function and generation of reactive oxygen species are deeply implicated in Parkinson's disease progression. Indeed, mutations in genes that affect mitochondrial function account for most of the familial cases of the disease, and post mortem studies in sporadic PD patients brains revealed increased signs of oxidative stress. Moreover, exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a mitochondrial complex I inhibitor, leads to clinical symptoms similar to sporadic PD. The bile acid tauroursodeoxycholic acid (TUDCA) is an anti-apoptotic molecule shown to protect against MPTP-induced neurodegeneration in mice, but the mechanisms involved are still incompletely identified. Herein we used MPTP-treated mice, as well as primary cultures of mice cortical neurons and SH-SY5Y cells treated with MPP

    Topics: Animals; Antioxidants; Male; Mice; Neuroprotective Agents; Parkinsonian Disorders; Taurochenodeoxycholic Acid; Ubiquitin-Protein Ligases

2017
Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease.
    Cell transplantation, 2002, Volume: 11, Issue:3

    There is accumulating evidence showing that the majority of cell death in neural grafts results from apoptosis when cells are implanted into the brain. Tauroursodeoxycholic acid (TUDCA), a taurine-conjugated hydrophilic bile acid, has been found to possess antiapoptotic properties. In the present study we have examined whether the supplementation of TUDCA to cell suspensions prior to transplantation can lead to enhanced survival of nigral grafts. We first conducted an in vitro study to examine the effects of TUDCA on the survival of dopamine neurons in serum-free conditions. The number of tyrosine hydroxylase (TH)-positive neurons in the TUDCA-treated cultures was significantly greater than that of control cultures 7 days in vitro. In addition, a terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) assay showed that the number of apoptotic cells in the TUDCA-treated cultures was dramatically smaller than that in the control cultures. In the transplantation study, a 50 microM concentration of TUDCA was added to the media when nigral tissue from Sprague-Dawley (SD) rats was trypsinized and dissociated. Two microliters of cell suspension containing TUDCA was then stereotaxically injected into the striatum of adult SD rats subjected to an extensive unilateral 6-hydroxydopamine lesion of the nigrastriatal dopamine pathway. At 2 weeks after transplantation, the rats that received a cell suspension with TUDCA exhibited a significant reduction in amphetamine-induced rotation scores when compared with pretransplantation value. There was a significant increase (approximately threefold) in the number of TH-positive cells in the neural grafts for the TUDCA-treated group when compared with the controls 6 weeks postgrafting. The number of apoptotic cells was much smaller in the graft areas in the TUDCA-treated groups than in the control group 4 days after transplantation. These data demonstrate that pretreatment of the cell suspension with TUDCA can reduce apoptosis and increase the survival of grafted cells, resulting in an improvement of behavioral recovery.

    Topics: Amphetamines; Animals; Apoptosis; Behavior, Animal; Brain Tissue Transplantation; Cell Transplantation; Cells, Cultured; Corpus Striatum; Culture Media, Serum-Free; Culture Techniques; Disease Models, Animal; Dopamine; Female; Graft Survival; In Situ Nick-End Labeling; Neurons; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Taurochenodeoxycholic Acid

2002